- Home
- GNLX vs GECC Comparison
GNLX vs GECC Comparison
Compare GNLX & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- GECC
- Stock Information
- Founded
- GNLX 2001
- GECC 2016
- Country
- GNLX United States
- GECC United States
- Employees
- GNLX N/A
- GECC N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- GECC Finance: Consumer Services
- Sector
- GNLX Health Care
- GECC Finance
- Exchange
- GNLX Nasdaq
- GECC Nasdaq
- Market Cap
- GNLX 128.0M
- GECC 127.9M
- IPO Year
- GNLX 2023
- GECC N/A
- Fundamental
- Price
- GNLX $3.91
- GECC $11.17
- Analyst Decision
- GNLX Strong Buy
- GECC Strong Buy
- Analyst Count
- GNLX 4
- GECC 1
- Target Price
- GNLX $17.75
- GECC $11.50
- AVG Volume (30 Days)
- GNLX 151.7K
- GECC 159.6K
- Earning Date
- GNLX 11-13-2025
- GECC 10-30-2025
- Dividend Yield
- GNLX N/A
- GECC 14.02%
- EPS Growth
- GNLX N/A
- GECC 29.91
- EPS
- GNLX N/A
- GECC 1.58
- Revenue
- GNLX N/A
- GECC $47,638,000.00
- Revenue This Year
- GNLX N/A
- GECC $28.14
- Revenue Next Year
- GNLX N/A
- GECC N/A
- P/E Ratio
- GNLX N/A
- GECC $6.89
- Revenue Growth
- GNLX N/A
- GECC 29.12
- 52 Week Low
- GNLX $1.95
- GECC $8.87
- 52 Week High
- GNLX $5.89
- GECC $11.45
- Technical
- Relative Strength Index (RSI)
- GNLX 59.55
- GECC 51.02
- Support Level
- GNLX $3.76
- GECC $10.79
- Resistance Level
- GNLX $3.61
- GECC $11.45
- Average True Range (ATR)
- GNLX 0.25
- GECC 0.16
- MACD
- GNLX 0.05
- GECC -0.03
- Stochastic Oscillator
- GNLX 67.03
- GECC 57.89
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.